{"id":"W4379282394","doi":"10.1200/jco.2023.41.16_suppl.tps3634","title":"Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health","keywords":"Medicine; Irinotecan; Internal medicine; Oxaliplatin; Oncology; Cohort; Regimen; Randomized controlled trial; Clinical endpoint; Prospective cohort study; Chemotherapy; Stage (stratigraphy); Adjuvant; Colorectal cancer; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004179657,0.0003922386,0.0005766299,0.0002633586,0.0001330657,0.0002476738,0.0003438498,0.0004525298,0.00846448],"category_scores_gemma":[0.0004164886,0.0001513492,0.0003041966,0.0003209613,0.0002945255,0.000175983,0.0002849816,0.001188328,0.001379028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000483254,"about_ca_system_score_gemma":0.0007466097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00107241,"about_ca_topic_score_gemma":0.003598238,"domain_scores_codex":[0.9998753,0.00004857903,0.00000676398,0.00002582681,0.00001901151,0.00002446717],"domain_scores_gemma":[0.9998038,0.00003064125,0.00003991261,0.00002630877,0.00001427238,0.00008502915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2199401,0.01157099,0.03041214,0.001704944,0.0005539642,0.0009293967,0.0001304187,0.003569583,0.0622347,0.001211115,0.02985852,0.6378843],"study_design_scores_gemma":[0.240557,0.5058345,0.1254255,0.0006265984,0.001507718,0.004685713,0.00007668678,0.005925034,0.02395058,0.00122862,0.09010955,0.00007262955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9642051,0.007696592,0.001313259,0.001877782,0.0003246252,0.002411279,0.003374453,0.0005242244,0.01827265],"genre_scores_gemma":[0.9767566,0.002723573,0.004082622,0.001103371,0.0001019068,0.00126769,0.004516228,0.00005177812,0.00939626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00846448,"threshold_uncertainty_score":0.0283165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1131859427903812,"score_gpt":0.465104857923732,"score_spread":0.3519189151333508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}